Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Lateral root initiation and formation within the parental root meristem of Cucurbita pepo: is auxin a key player?

Ilina EL, Kiryushkin AS, Semenova VA, Demchenko NP, Pawlowski K, Demchenko KN.

Ann Bot. 2018 Nov 3;122(5):873-888. doi: 10.1093/aob/mcy052.

PMID:
29684107
2.

On terahertz pulsed broadband Gauss-Bessel beam free-space propagation.

Kulya MS, Semenova VA, Bespalov VG, Petrov NV.

Sci Rep. 2018 Jan 23;8(1):1390. doi: 10.1038/s41598-018-19830-z.

3.

Validation of high throughput screening of human sera for detection of anti-PA IgG by Enzyme-Linked Immunosorbent Assay (ELISA) as an emergency response to an anthrax incident.

Semenova VA, Steward-Clark E, Maniatis P, Epperson M, Sabnis A, Schiffer J.

Biologicals. 2017 Jan;45:61-68. doi: 10.1016/j.biologicals.2016.09.012. Epub 2016 Nov 1.

4.

Humoral and Cell-Mediated Immune Responses to Alternate Booster Schedules of Anthrax Vaccine Adsorbed in Humans.

Quinn CP, Sabourin CL, Schiffer JM, Niemuth NA, Semenova VA, Li H, Rudge TL, Brys AM, Mittler RS, Ibegbu CC, Wrammert J, Ahmed R, Parker SD, Babcock J, Keitel W, Poland GA, Keyserling HL, El Sahly H, Jacobson RM, Marano N, Plikaytis BD, Wright JG.

Clin Vaccine Immunol. 2016 Apr 4;23(4):326-38. doi: 10.1128/CVI.00696-15. Print 2016 Apr.

5.

Effect of reduced dose schedules and intramuscular injection of anthrax vaccine adsorbed on immunological response and safety profile: a randomized trial.

Wright JG, Plikaytis BD, Rose CE, Parker SD, Babcock J, Keitel W, El Sahly H, Poland GA, Jacobson RM, Keyserling HL, Semenova VA, Li H, Schiffer J, Dababneh H, Martin SK, Martin SW, Marano N, Messonnier NE, Quinn CP.

Vaccine. 2014 Feb 12;32(8):1019-28. doi: 10.1016/j.vaccine.2013.10.039. Epub 2013 Dec 25.

PMID:
24373307
6.

A three-dose intramuscular injection schedule of anthrax vaccine adsorbed generates sustained humoral and cellular immune responses to protective antigen and provides long-term protection against inhalation anthrax in rhesus macaques.

Quinn CP, Sabourin CL, Niemuth NA, Li H, Semenova VA, Rudge TL, Mayfield HJ, Schiffer J, Mittler RS, Ibegbu CC, Wrammert J, Ahmed R, Brys AM, Hunt RE, Levesque D, Estep JE, Barnewall RE, Robinson DM, Plikaytis BD, Marano N; AVRP Laboratory Working Group.

Clin Vaccine Immunol. 2012 Nov;19(11):1730-45. doi: 10.1128/CVI.00324-12. Epub 2012 Aug 29.

7.

Validation and long term performance characteristics of a quantitative enzyme linked immunosorbent assay (ELISA) for human anti-PA IgG.

Semenova VA, Schiffer J, Steward-Clark E, Soroka S, Schmidt DS, Brawner MM, Lyde F, Thompson R, Brown N, Foster L, Fox S, Patel N, Freeman AE, Quinn CP.

J Immunol Methods. 2012 Feb 28;376(1-2):97-107. doi: 10.1016/j.jim.2011.12.002. Epub 2011 Dec 17.

PMID:
22197974
8.

A two-stage, multilevel quality control system for serological assays in anthrax vaccine clinical trials.

Soroka SD, Schiffer JM, Semenova VA, Li H, Foster L, Quinn CP.

Biologicals. 2010 Nov;38(6):675-83. doi: 10.1016/j.biologicals.2010.09.001. Epub 2010 Sep 28.

PMID:
20875951
9.

Effects of a reduced dose schedule and intramuscular administration of anthrax vaccine adsorbed on immunogenicity and safety at 7 months: a randomized trial.

Marano N, Plikaytis BD, Martin SW, Rose C, Semenova VA, Martin SK, Freeman AE, Li H, Mulligan MJ, Parker SD, Babcock J, Keitel W, El Sahly H, Poland GA, Jacobson RM, Keyserling HL, Soroka SD, Fox SP, Stamper JL, McNeil MM, Perkins BA, Messonnier N, Quinn CP; Anthrax Vaccine Research Program Working Group.

JAMA. 2008 Oct 1;300(13):1532-43. doi: 10.1001/jama.300.13.1532. Erratum in: JAMA. 2008 Nov 19;300(19):2252.

PMID:
18827210
10.

Standardized, mathematical model-based and validated in vitro analysis of anthrax lethal toxin neutralization.

Li H, Soroka SD, Taylor TH Jr, Stamey KL, Stinson KW, Freeman AE, Abramson DR, Desai R, Cronin LX, Oxford JW, Caba J, Pleatman C, Pathak S, Schmidt DS, Semenova VA, Martin SK, Wilkins PP, Quinn CP.

J Immunol Methods. 2008 Apr 20;333(1-2):89-106. doi: 10.1016/j.jim.2008.01.007. Epub 2008 Feb 8.

PMID:
18304568
11.

Analysis of anti-protective antigen IgG subclass distribution in recipients of anthrax vaccine adsorbed (AVA) and patients with cutaneous and inhalation anthrax.

Semenova VA, Schmidt DS, Taylor TH Jr, Li H, Steward-Clark E, Soroka SD, Ballard MM, Quinn CP.

Vaccine. 2007 Feb 26;25(10):1780-8. Epub 2006 Nov 27.

PMID:
17229495
12.

No evidence of a mild form of inhalational Bacillus anthracis infection during a bioterrorism-related inhalational anthrax outbreak in Washington, D.C., in 2001.

Baggett HC, Rhodes JC, Fridkin SK, Quinn CP, Hageman JC, Friedman CR, Dykewicz CA, Semenova VA, Romero-Steiner S, Elie CM, Jernigan JA.

Clin Infect Dis. 2005 Oct 1;41(7):991-7. Epub 2005 Aug 29.

PMID:
16142664
13.

Mass value assignment of total and subclass immunoglobulin G in a human standard anthrax reference serum.

Semenova VA, Steward-Clark E, Stamey KL, Taylor TH Jr, Schmidt DS, Martin SK, Marano N, Quinn CP.

Clin Diagn Lab Immunol. 2004 Sep;11(5):919-23.

14.

Specific, sensitive, and quantitative enzyme-linked immunosorbent assay for human immunoglobulin G antibodies to anthrax toxin protective antigen.

Quinn CP, Semenova VA, Elie CM, Romero-Steiner S, Greene C, Li H, Stamey K, Steward-Clark E, Schmidt DS, Mothershed E, Pruckler J, Schwartz S, Benson RF, Helsel LO, Holder PF, Johnson SE, Kellum M, Messmer T, Thacker WL, Besser L, Plikaytis BD, Taylor TH Jr, Freeman AE, Wallace KJ, Dull P, Sejvar J, Bruce E, Moreno R, Schuchat A, Lingappa JR, Martin SK, Walls J, Bronsdon M, Carlone GM, Bajani-Ari M, Ashford DA, Stephens DS, Perkins BA.

Emerg Infect Dis. 2002 Oct;8(10):1103-10.

15.

Inhalational anthrax outbreak among postal workers, Washington, D.C., 2001.

Dewan PK, Fry AM, Laserson K, Tierney BC, Quinn CP, Hayslett JA, Broyles LN, Shane A, Winthrop KL, Walks I, Siegel L, Hales T, Semenova VA, Romero-Steiner S, Elie C, Khabbaz R, Khan AS, Hajjeh RA, Schuchat A; Washington, D.C., Anthrax Response Team.

Emerg Infect Dis. 2002 Oct;8(10):1066-72.

16.

Opening a bacillus anthracis-containing envelope, Capitol Hill, Washington, D.C.: the public health response.

Hsu VP, Lukacs SL, Handzel T, Hayslett J, Harper S, Hales T, Semenova VA, Romero-Steiner S, Elie C, Quinn CP, Khabbaz R, Khan AS, Martin G, Eisold J, Schuchat A, Hajjeh RA.

Emerg Infect Dis. 2002 Oct;8(10):1039-43.

17.

A newly recognized virus associated with a fatal case of hantavirus pulmonary syndrome in Louisiana.

Morzunov SP, Feldmann H, Spiropoulou CF, Semenova VA, Rollin PE, Ksiazek TG, Peters CJ, Nichol ST.

J Virol. 1995 Mar;69(3):1980-3.

18.

[Laboratory diagnosis of pneumonia caused by Mycoplasma pneumoniae].

Baĭmomartov MS, Diuskalieva GU, Andruseva OG, Baĭmuratova MA, Semenova VA.

Vestn Akad Med Nauk SSSR. 1991;(6):47-9. Russian.

PMID:
1927040
19.

[HBs antigenemia in glomerulonephritis in children].

Shparvasser VV, Kanatbaeva AB, Temirbekov ZhT, Semenova VA.

Zh Mikrobiol Epidemiol Immunobiol. 1990 Apr;(4):73-6. Russian.

PMID:
2201149
20.

[Accelerated laboratory diagnosis of bacterial pneumonia].

Baĭzhomartov MS, Baĭmuratova MA, Semenova VA, Diuskalieva GU, Stetsenko OG.

Zh Mikrobiol Epidemiol Immunobiol. 1988 Aug;(8):36-9. Russian.

PMID:
3143206
21.

[Activity of the glycoprotein antigenic fractions of Mycoplasma pneumoniae in immunological reactions].

Semenova Va, Stetsenko OG, Diuskalieva GU, Baĭzhomartov MS.

Zh Mikrobiol Epidemiol Immunobiol. 1987 Nov;(11):56-9. Russian.

PMID:
3124417
22.

[Etiological structure of pneumonias in children and adults].

Baĭzhomartov MS, Stetsenko OG, Baĭmuratova MA, Semenova VA, Diuskalieva GU.

Zh Mikrobiol Epidemiol Immunobiol. 1987 Jul;(7):16-20. Russian.

PMID:
2960106
23.

[Rapid diagnosis of Mycoplasma pneumoniae infection by the counterimmunoelectrophoresis reaction].

Semenova VA, Stetsenko OG, Baĭmuratova MA, Baĭzhomartov MS.

Lab Delo. 1986;(5):291-3. Russian. No abstract available.

PMID:
2425138
24.

[Circulating immune complexes in the diagnosis of Mycoplasma pneumoniae infection].

Diuskalieva GU, Shuratov IKh, Baĭzhomartov MS, Semenova VA, Stetsenko OG.

Zh Mikrobiol Epidemiol Immunobiol. 1985 Dec;(12):58-62. Russian.

PMID:
3937399
25.

[Serum immunoglobulin in Mycoplasma pneumoniae infection].

Baĭzhomartov MS, Shuratov IKh, Semenova VA, Diuskalieva GU, Stetsenko OG.

Zh Mikrobiol Epidemiol Immunobiol. 1985 Feb;(2):68-72. Russian.

PMID:
3922183
26.

Analysis of anabolic steroids in body fluids by capillary gas chromatography with a two-channel detection system and a computer.

Uralets VP, Semenova VA, Yakushin MA, Semenov VA.

J Chromatogr. 1983 Nov 25;279:695-707.

PMID:
6689492
27.

[Comparative evaluation of some methods for primary screening of antineoplastic antibiotics in vitro].

Rudaia SM, Semenova VA, Osokina LI, Navashin SM.

Antibiotiki. 1970 Mar;15(3):259-63. Russian. No abstract available.

PMID:
5467761
28.

[Organ specific antigens in the human lung].

Trofimov GK, Semenova VA.

Biull Eksp Biol Med. 1970 Feb;69(2):75-8. Russian. No abstract available.

PMID:
4987421
29.

[Study of some actinomycetes forming closely related antiobiotics].

SEMENOVA VA, IL 'INSKAI SA, TAIG MM, MEL'NIKOVA AA, SHNEERSON AN, BUIANOVSKAIA IS, VESELOV NM.

Antibiotiki. 1963 Jan;8:12-8. Russian. No abstract available.

PMID:
13987891
30.

[Biological properties of actinomycetes of the red group with a mutating structure of their sporiferous hyphae].

SEMENOVA VA.

Antibiotiki. 1962 Dec;7:1057-63. Russian. No abstract available.

PMID:
13987890
31.

[Formation of actinoxanthine; a new anti-tumor antibiotic].

MEL'NIKOVA AA, SEMENOVA VA, SOLOV'EVA NK, SNEZHNOVA LP, GINZBURG GN.

Antibiotiki (Mosc). 1958 Jan-Feb;3(1):18-22. Russian. No abstract available.

PMID:
24544806
32.

[Selection of anti-cancer antibiotics producing strains of Actinomyces].

SOLOV'EVA NK, SEMENOVA VA, DELOVA ID, RUDAIA SM, IL'INSKAIA SA.

Antibiotiki (Mosc). 1958 Jan-Feb;3(1):3-7. Russian. No abstract available.

PMID:
24544802

Supplemental Content

Loading ...
Support Center